AXL and non-small cell lung carcinoma: Recently, Iaboni et al. [24] designed an aptamer-miRNA chimera system, consisting of GL21.T, an RNA aptamer recognizing the tyrosine kinase receptor Axl and miR-212 to target non-small-cell lung cancer (NSCLC) cells.